Immatics (IMTX) Other Working Capital Changes (2019 - 2026)
Immatics (IMTX) posted Other Working Capital Changes of -$5.3 million for Q4 2025, down 254.73% sequentially from -$1.5 million in Q3 2025, and down 870.14% YoY from $688175.4 in Q4 2024.
Analysis
Immatics (IMTX) Other Working Capital Changes (2019 - 2026) Analysis & Trends
Immatics has reported Other Working Capital Changes for 7 years, with the latest figure at -$5.3 million in Q4 2025.
- Quarterly Other Working Capital Changes fell 870.14% year-over-year to -$5.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$7.1 million (down 1017.67% YoY) and the FY2025 annual result came in at -$6.9 million, down 977.02% from the prior year.
- Other Working Capital Changes slipped to -$5.3 million in Q4 2025 per IMTX's latest filing, from -$1.5 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $729681.4 in Q4 2020 and troughed at -$7.1 million in Q2 2022.
- A 5-year average of -$993353.4 and a median of -$263749.4 in 2022 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2021 and 2025: Other Working Capital Changes surged 453.58% in 2021, then slumped 870.14% in 2025.
- Over 5 years, Other Working Capital Changes stood at -$367302.8 in 2021, then sank by 1486.05% to -$5.8 million in 2022, then soared by 182.19% to $4.8 million in 2023, then tumbled by 85.63% to $688175.4 in 2024, then plunged by 870.14% to -$5.3 million in 2025.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$5.3 million, -$1.5 million, and -$211676.5 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Immatics | 1.17 Bn | 711.21 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -840,387.62 |
| Jun 30, 2026 | -840,387.62 |
| Mar 31, 2026 | -889,766.69 |
| Mar 31, 2026 | -889,766.69 |
| Dec 31, 2025 | -870,704.55 |
| Dec 31, 2025 | -870,704.55 |
| Sep 30, 2025 | -862,762.66 |
| Sep 30, 2025 | -862,762.66 |
| Jun 30, 2025 | -833,122.33 |
| Jun 30, 2025 | -833,122.33 |
| Mar 31, 2025 | -775,238.83 |
| Mar 31, 2025 | -775,238.83 |
| Dec 31, 2024 | -837,778.79 |
| Dec 31, 2024 | -837,778.79 |
| Sep 30, 2024 | -912,620.41 |
| Sep 30, 2024 | -912,620.41 |
| Dec 31, 2020 | -170,497.45 |
| Dec 31, 2020 | -170,497.45 |
| Mar 31, 2020 | 760,613.99 |
| Mar 31, 2020 | 760,613.99 |